IP Library › Granted Patent US 9,861,570
Granted Patent B2
US 9,861,570 · App. 14/947,409 · Granted Jan 9, 2018

Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof

Inventors: Geoffrey C. Gurtner (Stanford, CA); Kenneth N. Horne (San Francisco, CA); Jayakumar Rajadas (Cupertino, CA)
Assignee: Allergan Holdings France S.A.S.
A61K8/735A61K8/027A61K8/0216A61K8/42A61K8/65A61L15/28A61L17/005A61L17/04A61L17/06A61L17/10A61L27/20A61L27/54A61L31/042A61Q19/08C08B37/0072C08L5/08A61K2800/805A61L2300/402A61L2430/34C08L2205/025Y10T428/2929
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,861,570
App. No.
14/947,409
Granted
Jan 9, 2018
Kind
B2
Abstract

The present invention provides threads of hyaluronic acid, and/or derivatives thereof, methods of making thereof and uses thereof, for example, in aesthetic applications (e.g., dermal fillers), surgery (sutures), drug delivery, etc.

Claims (10)

1. A method of treating a wrinkle in a subject comprising:

implanting a hydratable thread into the dermis of a subject in need thereof wherein the thread comprises uncrosslinked hyaluronic acid or salts, hydrates or solvates thereof and crosslinked hyaluronic acid or salts, hydrates or solvates thereof.

2. The method of claim 1 wherein the crosslinked hyaluronic acid is crosslinked with a crosslinker selected from the group consisting of butanediol diglycidyl ether (BDDE), divinyl sulfone (DVS) and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC).

3. The method of claim 1 wherein the crosslinked hyaluronic acid is crosslinked with butanediol diglycidyl ether (BDDE).

4. The method of claim 1 further comprising implanting the thread using a needle attached to the thread.

5. The method of claim 4 wherein the implanting comprises

inserting a distal end of the needle through the skin surface of the subject adjacent to the wrinkle;

traversing the dermis of the subject under the wrinkle with the needle;

forcing the needle through the skin surface of the subject; and

cutting the thread from the needle at the skin surface of the subject.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 30, 2015
From: TAUTONA GROUP L.P.
To: ALINE AESTHETICS, LLC
Reel/Frame 037382/0805 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 30, 2015
From: ALINE AESTHETICS, LLC
To: ALLERGAN HOLDINGS FRANCE S.A.S.
Reel/Frame 037382/0872 →
Continuity (3)
Continuation 13060919
Provisional Application 61190866 · Sep 2, 2008
Related Publication 20160074307A1 · Mar 17, 2016